Glaucoma decisions — 2025

The Board denied service connection for sleep apnea, a skin disorder, bilateral hand neuropathy, glaucoma with severe visual impairment, hypertension, diabetes mellitus, left lower extremity peripheral neuropathy, and right lower extremity peripheral neuropathy.

The Board remands the matters of entitlement to a rating in excess of 30 percent for the service-connected glaucoma of the right eye and entitlement to a total disability rating based on individual unemployability due to service-connected disabilities (TDIU) for additional evidentiary development.

The Board remands the Veteran's claims for service connection and increased ratings for various conditions, including ocular hypertension or glaucoma and right knee disabilities.

The Board granted an initial evaluation of 50 percent for left eye traumatic glaucoma, but dismissed the claims for special monthly compensation and earlier effective date.

The Board granted service connection for bilateral corticosteroid-induced glaucoma and remanded the issue of a higher initial disability rating for the right shoulder disability.

The Veteran's service-connected disabilities preclude him from securing or following a substantially gainful occupation, and therefore, a total disability rating based on individual unemployability (TDIU) is granted.

The Board granted service connection for cataracts, glaucoma, dry eye syndrome, and corneal dystrophy, finding that these conditions are due to the Veteran's service-connected traumatic brain injury.

The Board remands the issue of entitlement to service connection for a bilateral eye disability, to include glaucoma, pinguecula and cataracts, due to further development needed regarding exposure to PCP and an adequate medical opinion on the etiology of the Veteran's current eye conditions.

The Veteran withdrew the appeal for entitlement to a total disability rating based on individual unemployability (TDIU) before the Board promulgated a decision.

The Board granted service connection for glaucoma of the bilateral eyes as secondary to type II diabetes mellitus with background diabetic retinopathy and early cataract and erectile dysfunction, resolving reasonable doubt in favor of the Veteran.

The Board denied service connection for a low back disability and denied increased ratings for various disabilities, except for an initial 10% rating for neuropathy of the peroneal nerve in the right lower extremity.

The veteran has withdrawn the appeal for service connection and increased rating claims.

The Board remands the issues of entitlement to service connection for a left eye disability, to include glaucoma, and entitlement to a total disability rating based on individual unemployability (TDIU) due to service-connected disabilities for further development and adjudication.

The Board dismissed the claims for service connection for left and right upper and lower extremity peripheral neuropathy, glaucoma, as well as erectile dysfunction, vertigo, syncope, fatigue, hypertension, prostate cancer, and a heart disability due to the grant of service connection in an August 2024 rating decision.

The Board denied service connection for high cholesterol, right knee disability, and toenail fungus condition. The claims for a bilateral eye condition, low back disability, left and right lower extremity disabilities, leg muscle spasms, sleep disorder, heart condition, gout, GERD are remanded.

The Board granted service connection for right ear hearing loss, but remanded the claims for glaucoma and psychiatric disorder, as well as the evaluation of left ear hearing loss.

The Board denied the Veteran's claim for service connection for left eye glaucoma, finding that the evidence does not support a link between the condition and his in-service assault.

The Board denied service connection for hair loss, bilateral hearing loss, tinnitus, vision loss in both eyes (claimed as glaucoma and cataracts), and PTSD and bipolar disorder, to include nightmares, night sweats, and sleep disturbance.

The Board denied the Veteran's claim for an earlier effective date than May 3, 2023, for a 100 percent rating for bilateral, end-stage glaucoma with vitreous floaters.

The Board remands the claim for a VA examination to determine the impacts of the Veteran's service-connected disabilities on his ability to care for himself and his need for aid and attendance.